Medartis Holding AG (MED.SW)

CHF 53.5

(-2.19%)

Market Cap (In CHF)

727.35 Million

Revenue (In CHF)

212 Million

Net Income (In CHF)

619 Thousand

Avg. Volume

3154.00

Currency
CHF
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
44.15-90.0
PE
-
EPS
-
Beta Value
0.955
ISIN
CH0386200239
CUSIP
H54007101
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Dr. Christoph Bronnimann
Employee Count
-
Website
https://www.medartis.com
Ipo Date
2018-03-23
Details
Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. The company serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. Medartis Holding AG was founded in 1997 and is headquartered in Basel, Switzerland.

More Stocks